The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
The Quantum Mechanics Of Water
Researchers have now uncovered a small piece of the puzzle of how quantum mechanics affects hydrogen bonding in water.
Pressing Pause On Cell Membrane Movement
Researchers have developed an optogenetic process that stops cell membrane movements for observation purposes, akin to pressing a pause button.
Human Cytomegalovirus Linked To Autoimmune Disorders
A little-known virus has been associated with autoimmune disease as it triggers an immune response that also destroys natural killer cells in the body.
New Fluorescent Probes Help Solve Cell Membrane Mystery
Researchers have succeeded at observing how raft domains, active sections of the cell membrane with special groups of molecules, form in live cells.
Home-Based Palliative Care Just As Good Or Even Better
Cancer patients cared for at home tend to live longer than those in hospitals, according to a study from Japan.
DNA-DNA Interactions Could Influence Chromosome Structure
To carry out their roles, do DNA molecules interact with proteins—the prevailing hypothesis—or with each other? A study now provides direct evidence for the latter.
‘Dancing’ Electrons Could Enable Faster Data Encoding
With the addition of a special insulator, electrons in a magnetic hard disk engage in a ‘dance’ with their neighboring electrons to transfer magnetic information over a longer range.
Bats Follow Most Efficient Flight Path To Target Multiple Prey
Instead of foraging randomly for food, bats in fact select the most optimal flight route to capture two targets at once.
Multigene Sequencing Panel Detects Breast Cancer Early
Rather than testing them one by one, this test spots patients in India with risk of breast and ovarian cancers by using next-generation sequencing for a panel of genes.